Drug Giant Faced a Reckoning as China Took Aim at Bribery
China sought to make an example of GlaxoSmithKline in a case that involved bribery of doctors and investigators and ended with guilty pleas and record penalties
GSK China’s Private-Eyes Indicted in Shanghai for Illegal Probe
Peter William Humphrey, a 58-year-old Brit, and his wife Yu Ying Zeng, a 61-year old American, were arrested last August. Theirs is the first indictment Chinese prosecutors have announced on foreigners for illegal investigation.
Undercover Sex Tape Deepens GSK’s China Scandal
GlaxoSmithKline has confirmed the existence of a sex tape featuring Mark Reilly, the former manager at the centre of the company's corruption investigation.
Chinese Police Charge British Former Head of GSK in China With Bribery
The case is the biggest corruption scandal to hit a foreign company in China since the Rio Tinto affair in 2009, which resulted in four executives, including an Australian, being jailed for between 7-14 years.
Bribery in G.S.K. China Was Coordinated at Company Level
A Chinese police investigation into drugmaker GlaxoSmithKline has discovered that alleged bribery of doctors in China was coordinated by the British company and was not the work of individual employees, state media reported on September 3...
Corporate Sleuths On Edge After China Detains Foreign Consultants
The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline has had a chilling effect on other risk consultants working in China.
Conversation
07.30.13
Is Business in China Getting Riskier, Or Are Multinationals Taking More Risks?
Arthur Kroeber:
The environment for foreign companies in China has been getting steadily tougher since 2006, when the nation came to the end of a five-year schedule of market-opening measures it pledged as the price of admission...
Glaxo Chief Executive Addresses China Inquiry
Andrew Witty, chief executive of the drug maker GlaxoSmithKline, said on Wednesday that the accusations of bribery and corruption against his company in China were “deeply disappointing.” But he said that Glaxo’s headquarters in London had not...
More Foreign Pharmaceutical Firms Could Be Probed In China
China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery accusations against British drug maker GlaxoSmithKline. Corruption in China'...
Drug Research in China Falls Under a Cloud
A leaked document related to the recent G.S.K. scandal underscores the problems that can arise when major drug companies export their scientific development to emerging markets like China.
Glaxo Says Executives May Have Broken Chinese Law
The British pharmaceutical giant GlaxoSmithKline said Monday that some of its executives might have broken the law in China, the company’s strongest statement yet on a bribery and corruption scandal that has engulfed its China operations....
China Bars GlaxoSmithKline Executive From Leaving During a Bribery Inquiry
The effort to restrict Steve Nechelput’s travel came as the government ramped up an unusually bold anti-corruption campaign against GlaxoSmithKline, which is one of the world’s biggest drug makers.